guaifenesin has been researched along with Premature Birth in 3 studies
Guaifenesin: An expectorant that also has some muscle relaxing action. It is used in many cough preparations.
Premature Birth: CHILDBIRTH before 37 weeks of PREGNANCY (259 days from the first day of the mother's last menstrual period, or 245 days after FERTILIZATION).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Zierden, HC | 1 |
| DeLong, K | 1 |
| Zulfiqar, F | 1 |
| Ortiz, JO | 1 |
| Laney, V | 1 |
| Bensouda, S | 1 |
| Hernández, N | 1 |
| Hoang, TM | 1 |
| Lai, SK | 1 |
| Hanes, J | 1 |
| Burke, AE | 1 |
| Ensign, LM | 1 |
| Borboa-Olivares, H | 1 |
| Rodríguez-Sibaja, MJ | 1 |
| Espejel-Nuñez, A | 1 |
| Flores-Pliego, A | 1 |
| Mendoza-Ortega, J | 1 |
| Camacho-Arroyo, I | 1 |
| González-Camarena, R | 1 |
| Echeverría-Arjonilla, JC | 1 |
| Estrada-Gutierrez, G | 1 |
| Abo El-Ezz, AE | 1 |
| Askar, AE | 1 |
3 other studies available for guaifenesin and Premature Birth
| Article | Year |
|---|---|
Cervicovaginal mucus barrier properties during pregnancy are impacted by the vaginal microbiome.
Topics: Female; Humans; Infant, Newborn; Microbiota; Mucus; Pregnancy; Premature Birth; RNA, Ribosomal, 16S; | 2023 |
A Novel Predictive Machine Learning Model Integrating Cytokines in Cervical-Vaginal Mucus Increases the Prediction Rate for Preterm Birth.
Topics: Cervix Uteri; Cytokines; Female; Humans; Infant, Newborn; Interleukin-2; Mucus; Pregnancy; Premature | 2023 |
Predictive value of phosphorylated insulin-like growth factor binding protein-1 (PIGFBP-1) (bedside test) in preterm labor.
Topics: Female; Gene Expression Regulation; Humans; Immunoenzyme Techniques; Insulin-Like Growth Factor Bind | 2014 |